Immunogenic peptides of tumor associated antigen L6 and uses thereof in cancer therapy
AssigneeNational Health Research Institutes
InventorsShih-Jen Liu, Hsin-Wei Chen, Pele Choi-Sing Chong, Chih-Hsiang Leng
Life of this patent
Estimating the term…
Abstract
An immunopeptide containing a T cell epitope from the tumor associated antigen L6 (TAL6) and a nucleic acid encoding the immunopeptide are described herein. The immunopeptide or its encoding nucleic acid can be used as a component of an immune composition for enhancing immune response against cancer cells that express TAL6.
Claims8
An isolated immunopeptide, comprising the amino acid sequence of a T-cell epitope from the tumor associated antigen L6 (TAL6), wherein (i) the immunopeptide consists of the amino acid sequence of SEQ ID NO:2, or (ii) the T-cell epitope consists of the amino acid sequence of SEQ ID NO:4 and the immunopeptide has a maximum length of 50 amino acids.
Dependencies are inferred from the claim text.